THE Australian Competition and Consumer Commission yesterday issued a draft determination, proposing to grant authorisation to eRx Script Exchange to give effect to its ongoing revenue sharing arrangement with IP MDS Pty Ltd (formerly MediSecure) through until 30 Jun 2020.
The ACCC granted interim authorisation to the pact earlier this year (PD 07 Jun), allowing eRx and MDS to continue to operate their respective electronic prescription exchange systems interoperably, and share the fee that is paid to the dispensing pharmacist under the Sixth Community Pharmacy Agreement.
The ACCC will now consider submissions in response to the draft determination before issuing a final decision - see accc.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Sep 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Sep 17
